Advanced Genetic Tools for Studying Chlamydia

研究衣原体的先进遗传工具

基本信息

  • 批准号:
    10593742
  • 负责人:
  • 金额:
    $ 22.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-22 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Chlamydiae are obligate intracellular bacterial pathogens that cause disease in human and animal populations Chlamydia trachomatis is the major cause of both bacterial sexually transmitted disease and infectious blindness in the world. Despite great strides over the past decade, tools for genetic study and manipulation of Chlamydia spp. remain severely limited. This proposal will develop new and powerful genetic tools including tightly negatively regulated promoter expression systems, a Tn7-based single chromosomal insertion transgene system, and application of the latter to build new, smaller shuttle plasmids for transformation. Specific Aim 1 – Development of a tightly negatively regulated inducible promoter for Chlamydia. This aim will provide one of the key missing tools in the repertoire of genetic tools for Chlamydia: a tightly negatively regulated, inducible, and titratable promoter for performing expression / overexpression studies. In bacterial physiology studies, it is important to be able to express and overexpress cloned genes in a mutant or wild type genetic background. One also must be able to tightly repress the cloned gene to avoid undesirable phenotypes associated with leaky expression of the cloned gene. The two subaims will design and test inducible promoter systems derived from two well-established Escherichia coli systems: the lac operon and the arabinose operon. Both systems are tightly repressed in the absence of inducer and rapidly upregulated when inducer is present. Our rigorous validation plan will use three reporter genes to measure promoter activity in the presence and absence of inducer. The lac operon promoters will allow us to develop a range of promoters of varying induction strength and induction ratios to provide flexibility for future genetic studies. Specific Aim 2 – Development of a chromosomal Tn7 transgene insertion system for single copy gene complementation studies in Chlamydia. Shuttle plasmids used in Chlamydia complementation studies are based on the native Chlamydia plasmid, which is present at 7.6 copies per genome. The major shortcoming of expressing a cloned gene from a multi-copy plasmid is that even low copies of the plasmid may lead to non-physiological levels of gene expression and aberrant phenotypes that complicate interpretation of the complementation results. The Tn7 transgene system provides high frequency, site- specific, single copy chromosomal insertion of any gene with the additional advantage of removing the need for antibiotic selection for transgene maintenance. We will adapt the Tn7 transgene system to Chlamydia. Our proposal includes a rigorous strategy to test the transgene system and plans to optimize the system by selection for transposase mutants that more efficiently recognize the chlamydial Tn7 attachment site. We will apply the Tn7 transgene system to build and validate new, smaller shuttle plasmids, which should improve transformation efficiencies. We will make all tools developed in this proposal available to the research community. Thus, successful completion of these aims will enhance genetic studies in Chlamydia.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony T Maurelli其他文献

Anthony T Maurelli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony T Maurelli', 18)}}的其他基金

Peptidoglycan Assembly, Degradation, and Function in Pathogenic Chlamydia
致病性衣原体中肽聚糖的组装、降解和功能
  • 批准号:
    10062849
  • 财政年份:
    2016
  • 资助金额:
    $ 22.46万
  • 项目类别:
Antibiotic resistance and metabolic pathways in Chlamydia species
衣原体的抗生素耐药性和代谢途径
  • 批准号:
    7762442
  • 财政年份:
    2009
  • 资助金额:
    $ 22.46万
  • 项目类别:
Metabolic Modeling of Invasive Bacteria and HeLa Cytosol
入侵细菌和 HeLa 细胞溶质的代谢模型
  • 批准号:
    6809359
  • 财政年份:
    2004
  • 资助金额:
    $ 22.46万
  • 项目类别:
Metabolic Modeling of Invasive Bacteria and HeLa Cytosol
入侵细菌和 HeLa 细胞溶质的代谢模型
  • 批准号:
    6917788
  • 财政年份:
    2004
  • 资助金额:
    $ 22.46万
  • 项目类别:
MOLECULAR GENETIC ANALYSIS OF CHLAMYDIA PATHOGENICITY
衣原体致病性的分子遗传学分析
  • 批准号:
    6475516
  • 财政年份:
    1998
  • 资助金额:
    $ 22.46万
  • 项目类别:
MOLECULAR GENETIC ANALYSIS OF CHLAMYDIA PATHOGENICITY
衣原体致病性的分子遗传学分析
  • 批准号:
    2728334
  • 财政年份:
    1998
  • 资助金额:
    $ 22.46万
  • 项目类别:
Molecular Genetic Analysis of Chlamydia Pathogenicity
衣原体致病性的分子遗传学分析
  • 批准号:
    8447317
  • 财政年份:
    1998
  • 资助金额:
    $ 22.46万
  • 项目类别:
MOLECULAR GENETIC ANALYSIS OF CHLAMYDIA PATHOGENICITY
衣原体致病性的分子遗传学分析
  • 批准号:
    6124118
  • 财政年份:
    1998
  • 资助金额:
    $ 22.46万
  • 项目类别:
MOLECULAR GENETIC ANALYSIS OF CHLAMYDIA PATHOGENICITY
衣原体致病性的分子遗传学分析
  • 批准号:
    6624533
  • 财政年份:
    1998
  • 资助金额:
    $ 22.46万
  • 项目类别:
Molecular Genetic Analysis of Chlamydia Pathogenicity
衣原体致病性的分子遗传学分析
  • 批准号:
    8707934
  • 财政年份:
    1998
  • 资助金额:
    $ 22.46万
  • 项目类别:

相似海外基金

Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
  • 批准号:
    2902098
  • 财政年份:
    2024
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
  • 批准号:
    BB/Y004035/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
  • 批准号:
    EP/Z533026/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Research Grant
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
  • 批准号:
    FT230100468
  • 财政年份:
    2024
  • 资助金额:
    $ 22.46万
  • 项目类别:
    ARC Future Fellowships
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
  • 批准号:
    MR/Y033809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
  • 批准号:
    494853
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
  • 批准号:
    2904356
  • 财政年份:
    2023
  • 资助金额:
    $ 22.46万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了